Home Tags Therapeutics

Tag: Therapeutics

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Business

Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management

Editor -
0
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies
Business

EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies

Correspondent -
0
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)
Business

HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)

-
0
Gilboa Therapeutics Presents Pre-clinical Data at AACR Supporting SolidT Engineered T-Cell Platform Targeting Solid Tumors
Business

Gilboa Therapeutics Presents Pre-clinical Data at AACR Supporting SolidT Engineered T-Cell Platform Targeting Solid Tumors

-
0
Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer
Business

Microvascular Therapeutics Welcomes Thom Tulip as Chief Business Officer

-
0
Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments
Business

Prota Therapeutics US $21 Million Financing Led by SPRIM Global Investments

-
0
HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations
Business

HighTide Therapeutics Raises $107 Million in Series C/C+ Financing to Advance Innovative Pipeline and Business Collaborations

-
0
Biolexis Therapeutics Announces Poster Presentation at AACR 2022 Annual Meeting
Business

Biolexis Therapeutics Announces Poster Presentation at AACR 2022 Annual Meeting

-
0
Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets
Business

Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets

-
0
Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and the U.S. Successfully Listed on Main Board of SEHK
Business

Sirnaomics Ltd., the RNA Therapeutics Biopharmaceutical Company with Strong Presence in Both China and the U.S. Successfully Listed on Main Board of SEHK

-
0
Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201
Business

Parvus Therapeutics Announces Development and Manufacturing Agreement with Resilience to Advance Novel Autoimmune Drug Candidate PVT201

-
0
© Newspaper WordPress Theme by TagDiv